About Cannabis Innovation Summit
The use of cannabis for medicinal purposes has opened up a number of questions pertaining to the safety and efficacy for particular disease indications and long term use. This timely summit will discuss the questions that need to be addressed for the health and safety of patients using cannabis to treat disorders, ailments and disease as well as promote the essential evidence-based research that needs to take place in order to address some of these questions.
The Cannabis Innovation Summit will also launch the Toronto Cannabis & Cannabinoid Research Consortium (TC3) which brings together cannabis and cannabinoid researchers, scientists and clinicians from the University of Toronto and its affiliated hospital partners.
The Summit will focus on the drug development of cannabis and cannabinoid related therapies and drug delivery mechanisms from discovery to innovation. It will explore various clinical applications and trials around the assessment of the safety and efficacy of cannabis as a medicine and discuss important societal issues as it relates to mental and body health.
This event will also bring together scientists, government officials, policy-makers, research funding organizations and industry partners who are interested in research and innovation in this field. The goal of the summit is to offer the opportunity to network, seek new collaborations and share health research findings related to cannabis and cannabinoids. The symposium will feature talks and panel sessions, and will serve as an interactive platform to highlight preclinical, clinical and public health & policy research in Toronto.
Speakers
Agenda
8:00 – 8:30 am : Registration & Light Breakfast
8:30 – 8:45 am : Opening Remarks
Dr. Trevor Young
Dean, Faculty of Medicine, University of Toronto
8:45 – 9:00 am :
Launch of the Toronto Cannabis & Cannabinoid Research Consortium TC3
Steering Committee – Dr. Ruth Ross, Dr. Tony George, Dr. Lakshmi P. Kotra,
Dr. Romina Mizrahi, Dr. Bernard Le Foll
9:00 – 9:50 am : Panel Session – Discovery & Innovation
This panel discussion will focus on developing safe and effective cannabis and cannabinoid-related therapies and delivery mechanisms, from discovery to innovation. This panel will also discuss the urgent need to build research capacity in this field to study the harms and side effects of cannabis related therapies.
9:50 – 10:45 am :
Panel Session – Translation
The panel will focus on the evidence-based research on the use and safety of cannabis and cannabinoid-related therapies in various therapeutic areas including pain, epilepsy, psychiatry, movement disorders and neurodegenerative disease. This panel will also delve into issues around the concurrent use of cannabis and other medications by patients.
10:45 – 11:00 am : Short Break
11:00 – 11:50 am :
Panel Session : Society
This panel will focus on societal issues pertaining to mental and body health with discussions around youth psychiatry, maternal use and second hand smoke.
11:50 – 12:30 pm : Keynote Speaker – RBC Entrepreneurship & Innovation Speaker Series
12:30 – 1:30 pm : Lunch – Concluding Integrative Discussion – How do we make this work in Toronto?
1:30 – 2:30 pm : Closing Remarks – TC3 Launch Networking Event
A session to network with speakers and delegates from academia, industry, government and other sectors.
